A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with …

S Partridge, L Quadt, M Bolton, J Eccles, C Thompson… - Heliyon, 2023 - cell.com
Background Low dose naltrexone (LDN) is used off-label by many individuals with
fibromyalgia to help manage their pain. There is no current systematic literature review …

Opiate antagonists for chronic pain: a review on the benefits of low-dose Naltrexone in arthritis versus non-arthritic diseases

P Dara, Z Farooqui, F Mwale, C Choe, AJ van Wijnen… - Biomedicines, 2023 - mdpi.com
Chronic pain conditions create major financial and emotional burdens that can be
devastating for individuals and society. One primary source of pain is arthritis, a common …

Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia

H Naik, E Cooke, T Boulter, R Dyer, JN Bone, M Tsai… - BMJ open, 2024 - bmjopen.bmj.com
Introduction A significant proportion of individuals suffering from post COVID-19 condition
(PCC, also known as long COVID) can present with persistent, disabling fatigue similar to …

Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis

N Aitcheson, Z Lin, K Tynan - Australian Journal of General …, 2023 - search.informit.org
Background and objective Fibromyalgia is characterised by chronic, widespread
musculoskeletal pain and other systemic symptoms. Current pharmaceutical intervention …

Pharmacotherapeutic advances in fibromyalgia: what's new on the horizon?

P Sarzi-Puttini, V Giorgi, S Sirotti… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction This review delves into Fibromyalgia Syndrome (FMS), a chronic pain condition
demanding thorough understanding for precise diagnosis and treatment. Yet, a definitive …

[HTML][HTML] Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial …

AD Vatvani, P Patel, TI Hariyanto… - The Korean Journal of …, 2024 - synapse.koreamed.org
Background Fibromyalgia is characterized by the presence of chronic widespread pain that
may impair patient's quality of life. Currently, the use of naltrexone as a therapeutic agent for …

The Contribution of the Psychologist in the Assessment and Treatment of Fibromyalgia

JV Luciano, R Neblett, C Peñacoba… - … Treatment Options in …, 2023 - Springer
Purpose of review This review focuses on the role of psychologists in the assessment and
treatment of fibromyalgia syndrome (FMS), a highly prevalent condition characterized by …

[HTML][HTML] Naltrexona em baixa dose (LDN): tendência de consumo nas capitais brasileiras e Distrito Federal, 2014-2020

MG Schmidt, ILS Torres, DN Stahnke… - Ciência & Saúde …, 2023 - SciELO Public Health
Estudo ecológico com objetivo de determinar o consumo de naltrexona em baixa dose
(LDN) nas 26 capitais brasileiras e Distrito Federal e acompanhar a tendência entre os anos …

Further Discussion Regarding Multicancer Early Detection Tests

S Raoof, EA Klein - American Family Physician, 2024 - aafp.org
To the Editor: We would like to comment on several statements in the editorial on
multicancer early detection tests by Drs. Doubeni and Castle. 1 The editorial states that …

General Aspect of the Assessment and Management of the Poisonous Mushrooms in Turkiye

A Şahin, A Arici, S Korkut, Y Tunçok - Recent Trends in …, 2023 - dergipark.org.tr
Patients who exposed with poisonous mushrooms may apply to emergency services with a
serious clinical conditions ranging from simple gastrointestinal complaints to liver failure …